Walter

Melissa’s Data Tools Power ‘Know Your Business’ Strategies for Compliance and Accurate Risk Profiles

Retrieved on: 
Wednesday, September 20, 2023
Insurance, CTF, PEP, KYB, Narcotic, Bank statement, Person, Terrorism, Specially Designated Global Terrorist, Office of Foreign Assets Control, AML, Address, Specially Designated Nationals and Blocked Persons List, Risk, Washington Convention Center, Walter, OFAC, Terror, Government, News, KYC, Cryptocurrency

Complementing Know Your Customer (KYC) operations designed to identify individuals and their associated levels of risk, KYB strategies enable financial institutions to assess legitimacy and credibility of business customers in real time.

Key Points: 
  • Complementing Know Your Customer (KYC) operations designed to identify individuals and their associated levels of risk, KYB strategies enable financial institutions to assess legitimacy and credibility of business customers in real time.
  • Melissa will feature its KYB tools and services at Identity Week America 2023 , October 3-4, at the Walter E. Washington Convention Center in Washington, D.C., booth #247.
  • Melissa’s scalable KYB tools access trusted global data streams, such as credit bureaus, government agencies, and utility records, pairing data with recognized business registries or global regulators.
  • The company’s optimized KYB platform also streamlines access to data on global sanctions and politically exposed persons (PEP).

Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director And Enters Cooperation Agreement with Shareholder MKT Capital

Retrieved on: 
Thursday, September 21, 2023
Biotechnology, Pharmaceutical, Health, Faculty, University of Alberta, National Association Medical Staff Services, University, Doctor of Pharmacy, Medical laboratory, National Science Board, University of Alberta Faculty of Pharmacy and Pharmaceutical Sciences, Roche, Merrell Dow Pharmaceuticals Inc. v. Thompson, EDGAR, Associate, Chemistry, SEDAR, Lupus nephritis, Walter, Immunosuppression, Chair, Pharmaceutical industry, Management, Pharmacy, Aurinia

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors (“the Board”) has appointed Dr. Robert T. Foster to the Board.

Key Points: 
  • Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors (“the Board”) has appointed Dr. Robert T. Foster to the Board.
  • MKT Capital Ltd. (together with its affiliates, “MKT Capital”) submitted Dr. Foster as a candidate and worked collaboratively with Aurinia to name him to the Board.
  • In connection with Dr. Foster’s appointment, MKT Capital has entered into a cooperation agreement with Aurinia.
  • A complete copy of the cooperation agreement will be available on our profiles on EDGAR and SEDAR.

World-Renowned Orthopaedics Pioneer Joseph D. Zuckerman, MD, Receives Lifetime Achievement Award

Retrieved on: 
Wednesday, September 20, 2023
Glenoid labrum, Albert Einstein College of Medicine, Surgeon, William H. Harris (orthopaedic surgeon), Education, Lifetime Achievement Emmys, Professional, NYU, American Academy, NYU Langone Health, OSET, Patient, Walter, American Academy of Orthopaedic Surgeons, BPS Barbara Wilson Lifetime Achievement Award, Faculty, Knowledge, Extremities, Health, Orthopedic surgery, MPH, Nursing, Medical device, MD

"In our 13th year of the Orthopaedic Summit, I couldn't be prouder to present the Lifetime Achievement Award to Joseph D. Zuckerman," said Kevin Plancher, MD, MPH, FAOA, FAAOS, Founder of the Orthopaedic Summit, Clinical Professor of Orthopaedics at Albert Einstein College of Medicine.

Key Points: 
  • "In our 13th year of the Orthopaedic Summit, I couldn't be prouder to present the Lifetime Achievement Award to Joseph D. Zuckerman," said Kevin Plancher, MD, MPH, FAOA, FAAOS, Founder of the Orthopaedic Summit, Clinical Professor of Orthopaedics at Albert Einstein College of Medicine.
  • "I am honored OSET chose to award me the Lifetime Achievement award," Zuckerman said.
  • I would like to thank my colleagues for their passion and sharing the same vision to advance the field of orthopaedics.
  • "Dr. Zuckerman's extensive knowledge, leadership and professionalism exemplifies why he is a recipient of the Lifetime Achievement award," said Exactech Vice President of Extremities Marketing Emery Patton.

Leading Neuromuscular Expert Appointed Chief of Pediatric Orthopedic Surgery at Hassenfeld Children's Hospital at NYU Langone

Retrieved on: 
Wednesday, September 6, 2023
Communication, Human, Public, NYU, Spina bifida, New York University Grossman School of Medicine, Woman, Medicine, Cerebral palsy, Language, Female, Pediatric surgery, Foot, Hospital, MD, Patient, Division, Child, Love, Walter, Hassenfeld Children's Hospital, NYU Langone Health, Growth, American College, Orthopedic surgery, Health, Safety, Dentistry, Nursing

NEW YORK, Sept. 6, 2023 /PRNewswire/ -- Mara S. Karamitopoulos, MD, a renowned specialist in neuromuscular conditions, has been appointed chief of the Division of Pediatric Orthopedic Surgery in the Department of Orthopedic Surgery at NYU Grossman School of Medicine and lead for pediatric orthopedic surgery services at Hassenfeld Children's Hospital at NYU Langone .

Key Points: 
  • NEW YORK, Sept. 6, 2023 /PRNewswire/ -- Mara S. Karamitopoulos, MD, a renowned specialist in neuromuscular conditions, has been appointed chief of the Division of Pediatric Orthopedic Surgery in the Department of Orthopedic Surgery at NYU Grossman School of Medicine and lead for pediatric orthopedic surgery services at Hassenfeld Children's Hospital at NYU Langone .
  • Dr. Karamitopoulos , a clinical associate professor in the Department of Orthopedic Surgery, is a leader in the field of pediatric orthopedic surgery, having managed multidisciplinary teams since she joined NYU Langone in 2016.
  • She treats a variety of pediatric orthopedic conditions, specializing in care for children with cerebral palsy , spina bifida , and other neuromuscular conditions.
  • Thompson Professor of Orthopedic Surgery and chair of the Department of Orthopedic Surgery at the NYU Grossman School of Medicine.

Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

Retrieved on: 
Friday, September 1, 2023
Swiss Federal Institute of Technology, Swiss, Braunschweig, Scripps Research, Therapy, Biopharmaceutical, Ibete, Anticalin, CSO, Institute of technology, Biotechnology, Hansa, United States Air Force Scientific Advisory Board, Research, Science, Boehringer Ingelheim, Natural science, Executive Committee, Immunoglobulin G, Walter, Biology, Ghassan Hitto, Research fellow, Industrial Affairs Committee (Iceland), Technical University of Braunschweig, Swiss Federal Institute of Aquatic Science and Technology, Fine chemical, Sanofi

LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.

Key Points: 
  • LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.
  • Dr. Kaufmann joins Hansa from Pieris Pharmaceuticals where he has served as Chief Scientific Officer since 2019.
  • Søren Tulstrup, President and CEO, Hansa Biopharma said, "We are thrilled to welcome Hitto to Hansa at this pivotal time.
  • Dr. Hitto Kaufmann has served as Chief Scientific Officer at Pieris Pharmaceuticals since 2019.

Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

Retrieved on: 
Friday, September 1, 2023
Swiss Federal Institute of Technology, Swiss, Braunschweig, Scripps Research, Therapy, Biopharmaceutical, Ibete, Anticalin, CSO, Institute of technology, Biotechnology, Hansa, United States Air Force Scientific Advisory Board, Research, Science, Boehringer Ingelheim, Natural science, Executive Committee, Immunoglobulin G, Walter, Biology, Ghassan Hitto, Research fellow, Industrial Affairs Committee (Iceland), Technical University of Braunschweig, Swiss Federal Institute of Aquatic Science and Technology, Fine chemical, Sanofi

LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.

Key Points: 
  • LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.
  • Dr. Kaufmann joins Hansa from Pieris Pharmaceuticals where he has served as Chief Scientific Officer since 2019.
  • Søren Tulstrup, President and CEO, Hansa Biopharma said, "We are thrilled to welcome Hitto to Hansa at this pivotal time.
  • Dr. Hitto Kaufmann has served as Chief Scientific Officer at Pieris Pharmaceuticals since 2019.

Dr. Edward V. Ohanian Receives Walter F. Snyder Environmental Health Award from NSF and the National Environmental Health Association (NEHA)

Retrieved on: 
Thursday, August 3, 2023
Manufacturing, Health, General Health, Environmental Health, Utilities, Research, Oil, Gas, Environment, Energy, Science, Chemicals, Plastics, Occupational safety and health, Society, Drinking water, CIH, Public, Toxicokinetics, Safe Drinking Water Act, Associate, Drinking, Risk, Risk assessment, OST, George Washington, National Center for Healthy Housing, United States Environmental Protection Agency, Safe, NSF, Toxicology, NCEA, Toxicological Sciences, EPA, Human and Ecological Risk Assessment, Conference, Book, Arnold, Clean Water Act, Safety, Environmental impact assessment, US EPA, Environmental health, OW, ORD, Multimedia, Public health, Biophysical environment, WHO, Regulation, Letter, Milken Institute School of Public Health, The Woman Who Drinks, Doctor of Public Health, SOT, State, Walter, World Health Organization, Management, Medical device, Nursing

NSF , the leading global public health and safety organization, and the National Environmental Health Association (NEHA), which represents more than 6,000 members of the environmental health workforce, announced today that Dr. Edward V. Ohanian is the 2023 recipient of the Walter F. Snyder Environmental Health Award.

Key Points: 
  • NSF , the leading global public health and safety organization, and the National Environmental Health Association (NEHA), which represents more than 6,000 members of the environmental health workforce, announced today that Dr. Edward V. Ohanian is the 2023 recipient of the Walter F. Snyder Environmental Health Award.
  • Founded in 1971, the Snyder Award honors Walter F. Snyder, co-founder and first executive director of NSF, and individuals who, like him, pioneer environmental and public health through their careers.
  • Snyder Award nominations are open to the public, with recipients selected by a juror panel of environmental health leaders.
  • For more information about the Walter F. Snyder Award or to nominate a colleague for next year’s award, visit NSF’s website .

Louise Mirrer, Ph.D., President and CEO of the New-York Historical Society, Receives the First-Ever Walter W. Buckley Jr. Prize

Retrieved on: 
Friday, June 30, 2023
Education, Public engagement, Maine Historical Society, History, Vietnam War, New Yorker, Oliver E. Buckley Condensed Matter Prize, Walter, DFI, Louise Mirrer, Family, Management, Pharmaceutical industry

Dr. Mirrer, in all that she represents and has accomplished, is the perfect choice to be the initial recipient of this honor.

Key Points: 
  • Dr. Mirrer, in all that she represents and has accomplished, is the perfect choice to be the initial recipient of this honor.
  • We greatly appreciate Walter W. Buckley Jr. and his family for their devotion to this cause and for their important support."
  • Riccards adds, "This prize represents the idea that the story of America is still being written…the future course rests in our hands.
  • Mirrer also announced that she's chosen to donate the $30,000 prize fund to the New-York Historical Society.

Miller Law LLC and Motley Rice LLC Announce a Proposed Settlement in In re Zetia (Ezetimibe) Antitrust Litigation

Retrieved on: 
Tuesday, June 27, 2023
Class Action Lawsuit, Professional Services, Legal, Class, Magistrate, Vexatious litigation, District court, Notice, Court, Class representative, Pharmacy, Hearing, Clerk, FORM, Letter, Lawsuit, Ezetimibe, Fairness, Settlement, Court order, Singapore, Walter, Post office box, Summons, Insurance

The case name is In re Zetia (Ezetimibe) Antitrust Litigation, Civil Action No.

Key Points: 
  • The case name is In re Zetia (Ezetimibe) Antitrust Litigation, Civil Action No.
  • The Court has preliminarily approved the proposed settlement between the End-Payor Class and Defendants (the “Settlement”).
  • The proposed Settlement will provide for the payment of $70 million (the “Settlement Fund”) to resolve the End-Payor Class claims against Defendants.
  • The full text of the proposed Settlement Agreement, which is dated as of April 19, 2023, is available at www.InReZetiaAntitrustLitigation.com .

NovaBay Pharmaceuticals to Showcase its Full Line of Avenova Eyecare Products at the 126th Annual American Optometric Association Congress

Retrieved on: 
Tuesday, June 20, 2023
Biotechnology, Health, Cosmetics, Retail, Optical, Chek, Learning, Exhibition, Walter E. Washington Convention Center, NBY, AOA, Congress, Patient, Washington Convention Center, Walter, Conference, NYSE, NovaBay Pharmaceuticals, Pharmaceutical industry

(NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that it will showcase its Avenova®-branded eyecare products at the 126th Annual American Optometric Association (AOA) Congress & 55th Annual American Optometric Student Association (AOSA) Conference: Optometry's Meeting ® being held June 21-24, 2023 at the Walter E. Washington Convention Center in Washington, D.C.

Key Points: 
  • (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that it will showcase its Avenova®-branded eyecare products at the 126th Annual American Optometric Association (AOA) Congress & 55th Annual American Optometric Student Association (AOSA) Conference: Optometry's Meeting ® being held June 21-24, 2023 at the Walter E. Washington Convention Center in Washington, D.C.
  • The full line of Avenova dry eye products will be displayed at booth #821 in exhibition hall D&E.
  • “Through our physician-dispensed channel, we make our superior-quality products available for resale by eyecare professionals to their patients.
  • Eyecare professionals interested in learning more about the Avenova physician-dispensed program should email [email protected] or call 510-899-8841.